Fisher Historical Cash Flow

FPH Stock

34.52 0.67 1.98%

Analysis of Fisher Paykel cash flow over time is an excellent tool to project Fisher Paykel Healthcare future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 114.6 M or Capital Expenditures of 355.9 M as it is a great indicator of Fisher Paykel ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Fisher Paykel Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fisher Paykel Healthcare is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fisher Paykel Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Fisher Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Fisher balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Fisher's non-liquid assets can be easily converted into cash.

Fisher Paykel Cash Flow Chart

At this time, Fisher Paykel's End Period Cash Flow is comparatively stable compared to the past year. Begin Period Cash Flow is likely to gain to about 122.6 M in 2024, whereas Net Borrowings is likely to drop (4.2 M) in 2024.

Sale Purchase Of Stock Investments Capital Expenditures Change To Operating Activities Net Income Issuance Of Capital Stock

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Capital Expenditures

Capital Expenditures are funds used by Fisher Paykel Healthcare to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Fisher Paykel operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Fisher Paykel Healthcare financial statement analysis. It represents the amount of money remaining after all of Fisher Paykel Healthcare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most accounts from Fisher Paykel's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Fisher Paykel Healthcare current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fisher Paykel Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Fisher Paykel cash flow statement Correlations

	Sale Purchase Of Stock	Change To Inventory	Investments	Change In Cash	Net Borrowings	Depreciation	Dividends Paid	Capital Expenditures	Change To Account Receivables	Change To Operating Activities	Net Income	Change To Netincome	Change To Liabilities	Other Non Cash Items	End Period Cash Flow	Free Cash Flow	Begin Period Cash Flow	Stock Based Compensation	Change In Working Capital	Issuance Of Capital Stock
Sale Purchase Of Stock		0.44	-0.64	-0.35	-0.08	0.75	-0.53	0.81	-0.43	0.43	-0.03	-0.24	-0.52	0.39	0.54	-0.19	0.69	0.5	0.1	0.61
Change To Inventory	0.44		-0.42	-0.68	0.13	0.1	-0.77	0.24	-0.56	0.13	-0.76	-0.24	-0.64	0.58	-0.17	-0.66	0.22	-0.07	0.76	-0.23
Investments	-0.64	-0.42		0.39	0.02	-0.47	0.8	-0.56	0.34	-0.43	0.14	-0.22	0.2	-0.78	-0.18	-0.16	-0.39	-0.24	-0.18	-0.28
Change In Cash	-0.35	-0.68	0.39		-0.05	-0.27	0.7	-0.37	0.19	-0.1	0.46	0.42	0.54	-0.55	0.14	0.37	-0.41	-0.05	-0.66	-0.04
Net Borrowings	-0.08	0.13	0.02	-0.05		0.07	-0.06	0.03	0.02	-0.43	-0.05	0.1	-0.16	0.2	0.24	0.07	0.22	0.13	0.21	-0.07
Depreciation	0.75	0.1	-0.47	-0.27	0.07		-0.29	0.96	-0.25	0.46	0.45	-0.29	-0.32	0.35	0.88	0.26	0.95	0.87	-0.14	0.9
Dividends Paid	-0.53	-0.77	0.8	0.7	-0.06	-0.29		-0.42	0.38	-0.17	0.58	0.08	0.48	-0.8	0.09	0.29	-0.29	-0.01	-0.61	0.0
Capital Expenditures	0.81	0.24	-0.56	-0.37	0.03	0.96	-0.42		-0.38	0.51	0.34	-0.23	-0.3	0.51	0.78	0.2	0.92	0.81	-0.06	0.84
Change To Account Receivables	-0.43	-0.56	0.34	0.19	0.02	-0.25	0.38	-0.38		-0.19	0.15	-0.27	-0.05	-0.42	-0.09	0.12	-0.19	-0.21	0.05	-0.15
Change To Operating Activities	0.43	0.13	-0.43	-0.1	-0.43	0.46	-0.17	0.51	-0.19		0.27	-0.13	-0.11	0.34	0.37	0.14	0.43	0.45	0.01	0.35
Net Income	-0.03	-0.76	0.14	0.46	-0.05	0.45	0.58	0.34	0.15	0.27		0.21	0.53	-0.21	0.65	0.82	0.35	0.61	-0.8	0.67
Change To Netincome	-0.24	-0.24	-0.22	0.42	0.1	-0.29	0.08	-0.23	-0.27	-0.13	0.21		0.75	0.26	-0.19	0.59	-0.4	-0.18	-0.45	-0.2
Change To Liabilities	-0.52	-0.64	0.2	0.54	-0.16	-0.32	0.48	-0.3	-0.05	-0.11	0.53	0.75		-0.16	-0.19	0.7	-0.47	-0.13	-0.74	-0.04
Other Non Cash Items	0.39	0.58	-0.78	-0.55	0.2	0.35	-0.8	0.51	-0.42	0.34	-0.21	0.26	-0.16		0.09	0.13	0.39	0.23	0.42	0.06
End Period Cash Flow	0.54	-0.17	-0.18	0.14	0.24	0.88	0.09	0.78	-0.09	0.37	0.65	-0.19	-0.19	0.09		0.37	0.84	0.89	-0.32	0.84
Free Cash Flow	-0.19	-0.66	-0.16	0.37	0.07	0.26	0.29	0.2	0.12	0.14	0.82	0.59	0.7	0.13	0.37		0.14	0.39	-0.7	0.43
Begin Period Cash Flow	0.69	0.22	-0.39	-0.41	0.22	0.95	-0.29	0.92	-0.19	0.43	0.35	-0.4	-0.47	0.39	0.84	0.14		0.85	0.06	0.79
Stock Based Compensation	0.5	-0.07	-0.24	-0.05	0.13	0.87	-0.01	0.81	-0.21	0.45	0.61	-0.18	-0.13	0.23	0.89	0.39	0.85		-0.26	0.84
Change In Working Capital	0.1	0.76	-0.18	-0.66	0.21	-0.14	-0.61	-0.06	0.05	0.01	-0.8	-0.45	-0.74	0.42	-0.32	-0.7	0.06	-0.26		-0.49
Issuance Of Capital Stock	0.61	-0.23	-0.28	-0.04	-0.07	0.9	0.0	0.84	-0.15	0.35	0.67	-0.2	-0.04	0.06	0.84	0.43	0.79	0.84	-0.49

Click cells to compare fundamentals

Fisher Paykel Account Relationship Matchups

Fisher Paykel cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Sale Purchase Of Stock	15M	45.3M	7.5M	137.5M	158.1M	166.0M
Change To Inventory	(10.1M)	(114.1M)	(81.8M)	(6.5M)	45.4M	47.7M
Investments	15M	(202.6M)	80.3M	(11.3M)	(339M)	(322.1M)
Change In Cash	5.5M	49M	(800K)	32.2M	(35.9M)	(34.1M)
Net Borrowings	(14.9M)	(10.2M)	(14.1M)	(4.4M)	(4.0M)	(4.2M)
Total Cashflows From Investing Activities	(155.7M)	(387.3M)	(89.5M)	(11.3M)	(10.2M)	(10.7M)
Other Cashflows From Financing Activities	(9.7M)	(10.2M)	(14M)	(14.4M)	(16.8M)	(16.0M)
Depreciation	54.6M	74.0M	80.3M	87.9M	109.1M	114.6M
Dividends Paid	146.4M	181.3M	224.9M	195.7M	(145.5M)	(138.2M)
Capital Expenditures	170.7M	184.7M	169.8M	211.3M	339M	356.0M
Total Cash From Operating Activities	311.2M	574.8M	300.4M	222.9M	429.6M	451.1M
Change To Account Receivables	(62.7M)	(4.7M)	48.6M	(40.5M)	(38.5M)	(36.6M)
Net Income	278.2M	481.9M	349.1M	234.2M	132.6M	137.1M
Total Cash From Financing Activities	(159M)	(188M)	(235.8M)	(197.1M)	(128.7M)	(135.1M)
Other Cashflows From Investing Activities	(99.8M)	7.6M	15M	(202.6M)	(182.3M)	(173.2M)
Change To Netincome	1.4M	79.6M	(107.1M)	(41.9M)	(37.7M)	(35.8M)
Change To Liabilities	46.9M	65.7M	(5.7M)	(19M)	(21.9M)	(20.8M)
Other Non Cash Items	(21.6M)	18.9M	(129.0M)	(99.2M)	170.2M	178.7M
End Period Cash Flow	36.4M	85.4M	84.6M	116.8M	80.9M	84.9M
Free Cash Flow	140.5M	390.1M	130.6M	11.6M	90.6M	82.4M
Begin Period Cash Flow	30.9M	36.4M	85.4M	84.6M	116.8M	122.6M
Stock Based Compensation	5.9M	7.1M	7.5M	8.4M	10.8M	5.7M
Change In Working Capital	(72.8M)	(118.8M)	(33.2M)	(47.0M)	6.9M	7.2M
Issuance Of Capital Stock	2.3M	3.5M	3.2M	3M	3.5M	2.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Fisher Stock Analysis

When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC